14-day Premium Trial Subscription Try For FreeTry Free
$4.41
+0.0100 (+0.227%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $3.95 $5.27 Friday, 3rd May 2024 EGRX stock ended at $4.41. This is 0.227% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.54% from a day low at $4.24 to a day high of $4.60.
90 days $3.95 $6.81
52 weeks $3.95 $30.40

Historical Eagle Pharmaceuticals prices

Date Open High Low Close Volume
Jan 22, 2021 $48.14 $48.14 $47.00 $47.70 95 107
Jan 21, 2021 $48.40 $48.62 $47.22 $48.08 89 285
Jan 20, 2021 $50.18 $50.52 $48.03 $48.26 125 537
Jan 19, 2021 $50.57 $51.32 $50.03 $50.14 106 557
Jan 15, 2021 $50.23 $51.60 $49.63 $50.67 78 198
Jan 14, 2021 $49.53 $50.80 $49.25 $50.73 62 438
Jan 13, 2021 $49.56 $50.03 $49.10 $49.55 69 278
Jan 12, 2021 $50.30 $50.69 $49.28 $49.78 102 307
Jan 11, 2021 $49.25 $50.48 $48.98 $49.85 154 779
Jan 08, 2021 $50.94 $51.56 $48.95 $49.69 128 003
Jan 07, 2021 $50.07 $52.26 $50.07 $50.97 105 528
Jan 06, 2021 $50.34 $50.60 $48.52 $50.02 197 474
Jan 05, 2021 $48.43 $50.58 $47.73 $50.02 184 113
Jan 04, 2021 $46.77 $48.77 $46.60 $48.66 131 583
Dec 31, 2020 $46.51 $46.89 $45.47 $46.57 69 569
Dec 30, 2020 $46.36 $46.69 $45.45 $46.50 133 868
Dec 29, 2020 $46.41 $46.72 $45.65 $46.28 105 457
Dec 28, 2020 $46.29 $47.15 $45.66 $46.42 107 182
Dec 24, 2020 $47.43 $47.81 $45.98 $46.19 46 071
Dec 23, 2020 $47.29 $47.50 $46.84 $47.13 97 431
Dec 22, 2020 $46.82 $48.32 $46.82 $47.16 108 451
Dec 21, 2020 $47.47 $48.40 $46.73 $47.44 117 904
Dec 18, 2020 $46.82 $48.18 $46.01 $48.09 676 223
Dec 17, 2020 $46.18 $46.70 $44.22 $46.46 114 435
Dec 16, 2020 $46.97 $47.29 $45.86 $46.21 84 682
Click to get the best stock tips daily for free!

About Eagle Pharmaceuticals

Eagle Pharmaceuticals Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT